Osiris Therapeutics Appoints New Chief Financial Officer and Chief Business Officer
Go back to Osiris Therapeutics Appoints New Chief Financial Officer and Chief Business Officer| Osiris Therapeutics, Inc. (NASDAQ: OSIR) | Delayed: 18.99 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.99 | 52 Week High | $14.37 | |||
| Open | $25.07 | 52 Week Low | $3.55 | |||
| Day High | $18.99 | P/E | N/A | |||
| Day Low | $18.99 | EPS | $-0.28 | |||
| Volume | 0 | |||||
| Stryker Corp. (NYSE: SYK) | Delayed: 339.98 +8.61 (2.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $331.37 | 52 Week High | $123.55 | |||
| Open | $331.74 | 52 Week Low | $86.68 | |||
| Day High | $343.90 | P/E | 129.27 | |||
| Day Low | $331.00 | EPS | $2.63 | |||
| Volume | 2,178,826 | |||||
